{"id":"https://openalex.org/W2949235752","doi":null,"title":"Venetoclax Combo Therapy Shows Promise in Pediatric Patients with R/R AML","display_name":"Venetoclax Combo Therapy Shows Promise in Pediatric Patients with R/R AML","publication_year":2019,"publication_date":"2019-06-14","ids":{"openalex":"https://openalex.org/W2949235752","mag":"2949235752"},"language":"en","primary_location":{"id":"mag:2949235752","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/acute-myeloid-leukemia/venetoclax-combo-therapy-shows-promise-pediatric-patients-rr-aml","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083754415","display_name":"John Schieszer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John Schieszer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5083754415"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07217958,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-acute-myeloid-leukemia","display_name":"relapsed/refractory acute myeloid leukemia","score":0.9480000138282776},{"id":"https://openalex.org/keywords/pediatric-acute-myeloid-leukemia","display_name":"pediatric acute myeloid leukemia","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.8830000162124634},{"id":"https://openalex.org/keywords/idarubicin","display_name":"idarubicin","score":0.9810000061988831},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9664666652679443},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5853865742683411},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4106069505214691},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35655277967453003},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3235195279121399},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2376764714717865},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.08020976185798645}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2949235752","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/acute-myeloid-leukemia/venetoclax-combo-therapy-shows-promise-pediatric-patients-rr-aml","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3005124202","https://openalex.org/W4409731654","https://openalex.org/W4417004842","https://openalex.org/W2984974392","https://openalex.org/W2947052124","https://openalex.org/W4361008731","https://openalex.org/W4409889192","https://openalex.org/W7167703526","https://openalex.org/W4406932202","https://openalex.org/W4408301677"],"abstract_inverted_index":{"Early":[0],"data":[1],"on":[2],"the":[3],"safety":[4],"and":[5,10],"tolerability":[6],"of":[7],"combination":[8],"venetoclax":[9],"cytarabine":[11],"or":[12],"cytarabine/idarubicin":[13],"were":[14],"presented":[15],"at":[16],"ASCO":[17],"2019.":[18]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-06-27T00:00:00"}